Reshmi Srinath is an Endocrinology/Metabolic physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 29 publications with 349 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
87.7%GLP-1 receptor agonist36.6%Ozempic41%Trulicity39%Mounjaro15%Rybelsus6%Part D<11 patientsInsulin Analog17.4%Novolog Flexpen37%Lantus Solostar27%Basaglar Kwikpen U-10015%Humalog Kwikpen U-10010%Levemir Flexpen5%Tresiba Flextouch U-1005%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
6.8%l-Thyroxine6.8%Levothyroxine Sodium67%Synthroid33%Part D≥19 patientsCardiovascular
3.9%Statin3.9%Rosuvastatin Calcium50%Atorvastatin Calcium50%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Shifts in body mass index category with tirzepatide and associated changes in cardiometabolic risk factors in people with obesity: a post hoc analysis from the SURMOUNT-1 and SURMOUNT-4 trials
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”